NO147911C - Analogifremgangsmaate for fremstilling av fysiologisk aktive kinazolinon- og ftalazinon-derivater som er substituert med en substituert n-fenylalkylaminoalkylrest - Google Patents

Analogifremgangsmaate for fremstilling av fysiologisk aktive kinazolinon- og ftalazinon-derivater som er substituert med en substituert n-fenylalkylaminoalkylrest

Info

Publication number
NO147911C
NO147911C NO773010A NO773010A NO147911C NO 147911 C NO147911 C NO 147911C NO 773010 A NO773010 A NO 773010A NO 773010 A NO773010 A NO 773010A NO 147911 C NO147911 C NO 147911C
Authority
NO
Norway
Prior art keywords
substituted
phtalazinon
chinazolinon
phenylalkylaminoalkyl
residence
Prior art date
Application number
NO773010A
Other languages
English (en)
Norwegian (no)
Other versions
NO773010L (no
NO147911B (no
Inventor
Wolfgang Eberlein
Volkhard Austel
Joachim Heider
Juergen Daemmgen
Rudolf Kadatz
Christian Lillie
Walter Kobinger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO773010L publication Critical patent/NO773010L/no
Publication of NO147911B publication Critical patent/NO147911B/no
Publication of NO147911C publication Critical patent/NO147911C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Electroluminescent Light Sources (AREA)
  • Testing Or Measuring Of Semiconductors Or The Like (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO773010A 1976-09-01 1977-08-31 Analogifremgangsmaate for fremstilling av fysiologisk aktive kinazolinon- og ftalazinon-derivater som er substituert med en substituert n-fenylalkylaminoalkylrest NO147911C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762639291 DE2639291A1 (de) 1976-09-01 1976-09-01 Neue aryl-alkylamine

Publications (3)

Publication Number Publication Date
NO773010L NO773010L (no) 1978-03-02
NO147911B NO147911B (no) 1983-03-28
NO147911C true NO147911C (no) 1983-07-06

Family

ID=5986872

Family Applications (1)

Application Number Title Priority Date Filing Date
NO773010A NO147911C (no) 1976-09-01 1977-08-31 Analogifremgangsmaate for fremstilling av fysiologisk aktive kinazolinon- og ftalazinon-derivater som er substituert med en substituert n-fenylalkylaminoalkylrest

Country Status (32)

Country Link
US (1) US4134980A (fi)
JP (1) JPS5331685A (fi)
AT (1) AT350058B (fi)
AU (1) AU513302B2 (fi)
BE (1) BE858309A (fi)
BG (1) BG31378A3 (fi)
CA (1) CA1085838A (fi)
CS (1) CS197299B2 (fi)
DD (1) DD133945A5 (fi)
DE (1) DE2639291A1 (fi)
DK (1) DK148684C (fi)
ES (4) ES462005A1 (fi)
FI (1) FI63025C (fi)
FR (1) FR2363564A1 (fi)
GB (1) GB1544880A (fi)
GR (1) GR63624B (fi)
HK (1) HK33582A (fi)
HU (1) HU175549B (fi)
IE (1) IE45672B1 (fi)
IL (1) IL52853A (fi)
LU (1) LU78049A1 (fi)
MY (1) MY8300057A (fi)
NL (1) NL7709577A (fi)
NO (1) NO147911C (fi)
NZ (1) NZ185061A (fi)
PH (1) PH13994A (fi)
PL (2) PL103564B1 (fi)
PT (1) PT66975B (fi)
RO (1) RO73286A (fi)
SE (1) SE442866B (fi)
SU (2) SU665802A3 (fi)
ZA (1) ZA775262B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
IT1222867B (it) * 1987-10-12 1990-09-12 Zambon Spa Ftalazino derivati ad attivita' farmaceutica
IT1229118B (it) * 1988-07-29 1991-07-22 Simes Composti attivi sul sistema cardiovascolare che presentano sia la struttura dei beta-bloccanti sia una porzione calcio-antagonista
JP6895002B1 (ja) 2020-05-27 2021-06-30 ウィンボンド エレクトロニクス コーポレーション 半導体記憶装置および読出し方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2020234A1 (de) * 1970-04-25 1971-11-18 Cassella Farbwerke Mainkur Ag Basisch substituierte Derivate des 4(3H)-Chinazolinons
US3829420A (en) * 1970-07-13 1974-08-13 Sumitomo Chemical Co 3,4-dihydro-2(1h)-quinazolinones and preparation thereof
US3905976A (en) * 1971-11-24 1975-09-16 Sandoz Ag Substituted tricyclic quinazolinones

Also Published As

Publication number Publication date
AU2842477A (en) 1979-03-08
PH13994A (en) 1980-11-28
MY8300057A (en) 1983-12-31
JPS613787B2 (fi) 1986-02-04
GR63624B (en) 1979-11-27
GB1544880A (en) 1979-04-25
SU665802A3 (ru) 1979-05-30
BE858309A (fr) 1978-02-28
SE7709816L (sv) 1978-03-02
NO773010L (no) 1978-03-02
HK33582A (en) 1982-07-30
DK148684B (da) 1985-09-02
AT350058B (de) 1979-05-10
IE45672B1 (en) 1982-10-20
PT66975B (de) 1979-07-13
RO73286A (ro) 1981-08-17
SU837323A3 (ru) 1981-06-07
FI772261A (fi) 1978-03-02
US4134980A (en) 1979-01-16
SE442866B (sv) 1986-02-03
AU513302B2 (en) 1980-11-27
PL103564B1 (pl) 1979-06-30
IL52853A (en) 1980-07-31
DK367077A (da) 1978-03-02
FI63025B (fi) 1982-12-31
ES462005A1 (es) 1978-06-16
PL200570A1 (pl) 1978-05-22
ES465562A1 (es) 1978-09-16
ZA775262B (en) 1979-04-25
JPS5331685A (en) 1978-03-25
ES465561A1 (es) 1978-09-16
DK148684C (da) 1986-02-17
BG31378A3 (bg) 1981-12-15
HU175549B (en) 1980-08-28
IL52853A0 (en) 1977-10-31
FR2363564B1 (fi) 1981-05-29
LU78049A1 (fi) 1978-09-14
FR2363564A1 (fr) 1978-03-31
FI63025C (fi) 1983-04-11
NZ185061A (en) 1980-03-05
ES465560A1 (es) 1978-09-16
NL7709577A (nl) 1978-03-03
CA1085838A (en) 1980-09-16
PL103691B1 (pl) 1979-07-31
DE2639291C2 (fi) 1987-05-27
CS197299B2 (en) 1980-04-30
PT66975A (de) 1977-09-01
NO147911B (no) 1983-03-28
ATA600577A (de) 1978-10-15
IE45672L (en) 1978-03-01
DE2639291A1 (de) 1978-03-02
DD133945A5 (de) 1979-01-31

Similar Documents

Publication Publication Date Title
NO149035C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
NO784231L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive benzotiazinderivater
NO145657C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkenderivater.
NO782127L (no) Fremgangsmaate for fremstilling av fysiologisk aktive isoksazolo-pyridin-derivater
NO801415L (no) Fremgangsmaate for fremstilling av antibakterielt aktive bisestere av metandiol med penicillinderivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO150397C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylderivater av aminosyrer
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO159019C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater.
NO895087L (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater.
NO773384L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO774126L (no) Fremgangsmaate for fremstilling av tiazolidin- og tiazanderivater
NO773327L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
NO834363L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
NO149502C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive aminoalkoksyfenylderivater
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
NO147911C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive kinazolinon- og ftalazinon-derivater som er substituert med en substituert n-fenylalkylaminoalkylrest
NO149314C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive imidazoisokinolindioner
SE7800930L (sv) Forfarande for framstellning av bensensulfonamid- och bensenkarboxamidderivat med terapeutisk verkan
NO784325L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater